BIRC5 and esophageal squamous cell carcinoma: Here, we examined the expression of survivin and SLC35F2, responsible for YM155 uptake, in multiple esophageal cell lines, testing the antitumor activity of relevant YM155 concentrations against ESCC both in vitro and in vivo.